Prostate Cancer
Health-related quality of life 24-month after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study.
January 15, 2021
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study.
January 15, 2021
Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.
January 15, 2021
Cost-Effectiveness Assessment of Monitoring Abiraterone Levels in Metastatic Castration-Resistant Prostate Cancer Patients.
January 15, 2021
Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current Limitations.
January 14, 2021
Clinical and Biological Features of Neuroendocrine Prostate Cancer.
January 14, 2021
Targeting p300/CBP axis in lethal prostate cancer.
January 14, 2021
Should Grade Group 1 (GG1) be called cancer?
January 14, 2021
Metabolic syndrome predicts worse perioperative outcomes in patients treated with radical prostatectomy for non-metastatic prostate cancer.
January 13, 2021
Integration of electronic pathology reporting with clinical trial matching for advanced prostate cancer.
January 13, 2021
BRCA2, ATM, and CDK12 defects differentially shape prostate tumor driver genomics and clinical aggression.
January 12, 2021